The voltage-gated potassium channel Kv1. 3 is a promising multitherapeutic target against human pathologies

M Perez-Verdaguer, J Capera… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: The voltage-dependent potassium channel Kv1. 3 is mainly present in the
nervous and immune systems. In leukocytes, Kv1. 3 fine-tunes the activation and …

The voltage-gated potassium channel KV1. 3 as a therapeutic target for venom-derived peptides

G Tajti, DCC Wai, G Panyi, RS Norton - Biochemical pharmacology, 2020 - Elsevier
The voltage-gated potassium channel KV 1.3 is a well-established therapeutic target for a
range of autoimmune diseases, in addition to being the site of action of many venom-derived …

Differential Kv1. 3, KCa3. 1, and Kir2. 1 expression in “classically” and “alternatively” activated microglia

HM Nguyen, EM Grössinger, M Horiuchi, KW Davis… - Glia, 2017 - Wiley Online Library
Microglia are highly plastic cells that can assume different phenotypes in response to
microenvironmental signals. Lipopolysaccharide (LPS) and interferon‐γ (IFN‐γ) promote …

Discovery of KV1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges

Š Gubič, LA Hendrickx, Ž Toplak… - Medicinal research …, 2021 - Wiley Online Library
Abstract The KV1. 3 voltage‐gated potassium ion channel is involved in many physiological
processes both at the plasma membrane and in the mitochondria, chiefly in the immune and …

Venom-derived peptide inhibitors of voltage-gated potassium channels

RS Norton, KG Chandy - Neuropharmacology, 2017 - Elsevier
Voltage-gated potassium channels play a key role in human physiology and pathology.
Reflecting their importance, numerous channelopathies have been characterised that arise …

T cells in vascular inflammatory diseases

LL Lintermans, CA Stegeman, P Heeringa… - Frontiers in …, 2014 - frontiersin.org
Inflammation of the human vasculature is a manifestation of many different diseases ranging
from systemic autoimmune diseases to chronic inflammatory diseases, in which multiple …

Prolonged immunomodulation in inflammatory arthritis using the selective Kv1. 3 channel blocker HsTX1 [R14A] and its PEGylated analog

MR Tanner, RB Tajhya, R Huq, EJ Gehrmann… - Clinical …, 2017 - Elsevier
Effector memory T lymphocytes (T EM cells) that lack expression of CCR7 are major drivers
of inflammation in a number of autoimmune diseases, including multiple sclerosis and …

Regulatory role of KCa3. 1 in immune cell function and its emerging association with rheumatoid arthritis

Y Lin, YJ Zhao, HL Zhang, WJ Hao, RD Zhu… - Frontiers in …, 2022 - frontiersin.org
Rheumatoid arthritis (RA) is a common autoimmune disease characterized by chronic
inflammation. Immune dysfunction is an essential mechanism in the pathogenesis of RA and …

How the potassium channel response of T lymphocytes to the tumor microenvironment shapes antitumor immunity

M Chirra, HS Newton, VS Gawali, TM Wise-Draper… - Cancers, 2022 - mdpi.com
Simple Summary Ion channels are proteins that control the movement of ions across the
membranes of cells, thus regulating their physiological functions. In T lymphocytes, ion …

Peripheral administration of the KV1. 3-blocking peptide HsTX1 [R14A] improves cognitive performance in senescence accelerated SAMP8 mice

Y Pan, Y Kagawa, J Sun, DSD Lucas, R Takechi… - …, 2023 - Springer
Increased expression of the voltage-gated potassium channel Kv1. 3 in activated microglia,
and the subsequent release of pro-inflammatory mediators, are closely associated with the …